Failure of RB1 to reverse the malignant phenotype of human tumor cell lines - PubMed (original) (raw)
. 1992 Feb 1;52(3):654-61.
Affiliations
- PMID: 1732054
Failure of RB1 to reverse the malignant phenotype of human tumor cell lines
M M Muncaster et al. Cancer Res. 1992.
Abstract
In addition to retinoblastoma and osteosarcoma, mutation of both alleles of the RB1 gene occurs frequently in several other types of tumors. In order to evaluate the role of RB1 in cancer, the wild type RB1 gene was introduced into the RB1-deleted breast cancer cell line MDA-468-S4 and retinoblastoma cell lines WERI-Rb1 and Y-79. The RB1 complementary DNA was under control of the inducible murine metallothionein promoter in MDA-468-S4 and the thymidine kinase promoter in the retinoblastoma lines. The protein, p110RB1, produced from the exogenously introduced gene appeared normal by immunoprecipitation, Western blot analysis, and nuclear localization and also showed normal cell cycle-dependent phosphorylation and an ability to bind to E1a protein. No changes in growth rate or morphology were observed in either of the reconstituted cell types. Expression of p110RB1 in MDA-468-S4 did not affect anchorage-independent growth when measured by colony formation in soft agar. Although the ability of WERI-Rb1 cells expressing p110RB1 to form colonies in methylcellulose was reduced, the reconstituted retinoblastoma cell lines formed intraocular tumors in immunodeficient mice with the same efficiency as the RB1-negative parent cell lines and the tumors produced by the RB1-reconstituted cells continued to express p110RB1. These experimental results suggest that the malignant phenotype is little affected by the replacement of p110RB1 and that RB1 is a relatively weak tumor suppressor gene.
Similar articles
- RB1 oncosuppressor gene over-expression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells.
Valente P, Melchiori A, Paggi MG, Masiello L, Ribatti D, Santi L, Takahashi R, Albini A, Noonan DM. Valente P, et al. Oncogene. 1996 Sep 19;13(6):1169-78. Oncogene. 1996. PMID: 8808691 - The retinoblastoma protein and the cell cycle.
Sopta M, Gallie BL, Gill RM, Hamel PA, Muncaster M, Zacksenhaus E, Phillips RA. Sopta M, et al. Semin Cancer Biol. 1992 Jun;3(3):107-13. Semin Cancer Biol. 1992. PMID: 1511153 Review. - Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13.
Banerjee A, Xu HJ, Hu SX, Araujo D, Takahashi R, Stanbridge EJ, Benedict WF. Banerjee A, et al. Cancer Res. 1992 Nov 15;52(22):6297-304. Cancer Res. 1992. PMID: 1423276 - Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA. Huang L, et al. Mol Carcinog. 1996 Feb;15(2):85-95. doi: 10.1002/(SICI)1098-2744(199602)15:2<85::AID-MC1>3.0.CO;2-Q. Mol Carcinog. 1996. PMID: 8599583 - The genetics of retinoblastoma.
Stahl A, Levy N, Wadzynska T, Sussan JM, Jourdan-Fonta D, Saracco JB. Stahl A, et al. Ann Genet. 1994;37(4):172-8. Ann Genet. 1994. PMID: 7710251 Review.
Cited by
- An optimized gene transfection system in WERI-Rb1 cells.
Liu Y, Fan Z, Li K, Deng F, Xiong Y, Liang M, Ge J. Liu Y, et al. Int J Mol Med. 2017 Sep;40(3):801-813. doi: 10.3892/ijmm.2017.3058. Epub 2017 Jul 6. Int J Mol Med. 2017. PMID: 28713896 Free PMC article. - Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.
Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. Jiang Z, et al. J Clin Invest. 2010 Sep;120(9):3296-309. doi: 10.1172/JCI41490. Epub 2010 Aug 2. J Clin Invest. 2010. PMID: 20679727 Free PMC article. - Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells.
Cobrinik D, Francis RO, Abramson DH, Lee TC. Cobrinik D, et al. Mol Cancer. 2006 Dec 12;5:72. doi: 10.1186/1476-4598-5-72. Mol Cancer. 2006. PMID: 17163992 Free PMC article. - Mutations and regulatory anomalies effecting tumor cell immune functions.
Blanck G. Blanck G. Cancer Immunol Immunother. 2004 Jan;53(1):1-16. doi: 10.1007/s00262-003-0418-3. Epub 2003 Sep 12. Cancer Immunol Immunother. 2004. PMID: 13680191 Free PMC article. Review. - Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter.
Osborne A, Tschickardt M, Blanck G. Osborne A, et al. Nucleic Acids Res. 1997 Dec 15;25(24):5095-102. doi: 10.1093/nar/25.24.5095. Nucleic Acids Res. 1997. PMID: 9396821 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous